Moderna Inc MRNA.O said on Tuesday it has completed its submission to the U.S. Food and Drug Administration for the emergency use authorization of its COVID-19 booster shot tailored against the BA.4 and BA.5 subvariants of Omicron. Great!
Photo Credit: Mufid Majnun